Filippone, A.; Mannino, D.; Casili, G.; Lanza, M.; Paterniti, I.; Cuzzocrea, S.; Capra, A.P.; Colarossi, L.; Giuffrida, D.; Lombardo, S.P.;
et al. Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management. Int. J. Mol. Sci. 2022, 23, 15693.
https://doi.org/10.3390/ijms232415693
AMA Style
Filippone A, Mannino D, Casili G, Lanza M, Paterniti I, Cuzzocrea S, Capra AP, Colarossi L, Giuffrida D, Lombardo SP,
et al. Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management. International Journal of Molecular Sciences. 2022; 23(24):15693.
https://doi.org/10.3390/ijms232415693
Chicago/Turabian Style
Filippone, Alessia, Deborah Mannino, Giovanna Casili, Marika Lanza, Irene Paterniti, Salvatore Cuzzocrea, Anna Paola Capra, Lorenzo Colarossi, Dario Giuffrida, Sofia Paola Lombardo,
and et al. 2022. "Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management" International Journal of Molecular Sciences 23, no. 24: 15693.
https://doi.org/10.3390/ijms232415693
APA Style
Filippone, A., Mannino, D., Casili, G., Lanza, M., Paterniti, I., Cuzzocrea, S., Capra, A. P., Colarossi, L., Giuffrida, D., Lombardo, S. P., & Esposito, E.
(2022). Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management. International Journal of Molecular Sciences, 23(24), 15693.
https://doi.org/10.3390/ijms232415693
